Curida Announces Strategic Partnership with Rommelag

November 2025

Curida Announces Strategic Partnership with Rommelag — Bringing Europe’s First BFS 550 Line to Norway

October 2025 — Curida is proud to announce a new strategic partnership with Rommelag, the global leader in Blow-Fill-Seal (BFS) technology.
As part of this collaboration, Curida will become the first company in Europe to install Rommelag’s latest BFS bottelpack 550 system — a next-generation platform designed to deliver greater flexibility, higher output, and enhanced sustainability in sterile liquid manufacturing.

The partnership strengthens Curida’s position as a European CDMO leader in Nasal & Ophthalmic solutions, expanding capacity and capability for both existing and new customers in sprays, ophthalmics, wound care, controlled drugs and other aseptic & non-aseptic applications.

“This investment marks an important step forward in Curida’s growth journey,” says Anders Larsson, CEO of Curida. “Working closely with Rommelag ensures we continue to offer our clients & partners the most advanced, efficient, and sustainable solutions in Blow-Fill-Seal manufacturing.”

The two teams met in Frankfurt during CPhI Worldwide 2025 to mark the beginning of this exciting collaboration.
A partnership built on innovation, trust, and shared commitment to quality.

More Resources

Join Curida at PharmaSynergy-OTC, Rome, 10- 11 September

If you’re attending and would like to discuss o...
14.05.2026

Curida Streamlines Quality Processes with AFRY

To support continued growth, remain future-read...
17.02.2026

Curida Achieves Eco Vadis Bronze Award

Over the past year, Curida has completed a doub...
13.02.2026

Controlled Drugs Manufacturing in Europe: Regulation, Nasal Delivery and CDMO Expertise

In this in-depth article, Curida examines how d...
03.02.2026

Join Curida at euroPLX, Lisbon: 2-3 March 2026

We’re excited to join industry peers at euroPLX...
28.01.2026

Join Curida at euroPLX, Warsaw: 8-9 June 2026

We’re excited to join industry peers at euroPLX...
28.01.2026

Join Curida at CPHi WW, Milan: 6-8 October 2026

We’re excited to join industry peers at CPHi WW...
28.01.2026

Making Critical Therapies More Accessible with Nasal Sprays

Álvaro López, Business Development Director at ...
15.09.2025

Curida Launches New Website & Brand Refresh

Curida AS, a leading European Contract Developm...
10.09.2025

Nasal Sprays & Suspensions

When it comes to nasal spray drug products, the...
23.06.2025